Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting
April 27, 2021 17:47 ET | Source: Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceutical Inc. Novato, California, UNITED STATES
NOVATO, Calif., April 27, 2021 (GLOBE NEWSWIRE) Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today announced that clinical, preclinical and manufacturing data from its investigational gene therapy programs will be presented at the American Society of Gene & Cell Therapy (ASGCT) 24
th Annual Meeting, which will be held virtually May 11-14, 2021.
“We continue to advance our proprietary HeLa producer cell line (PCL) manufacturing platform and look forward to sharing recent HeLa 3.0 improvements that further increase productivity and reproducibility of
Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
RESEARCH TRIANGLE PARK - StrideBio, an emerging startup focusing on gene therapies which closed on a big $81.5 million round of venture capital in March, is
Antion Biosciences to Present at Upcoming Scientific Conferences finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Dr. Verardi is currently an Associate Professor of Virology and Vaccinology in the Department of Pathobiology at the University of Connecticut (UConn), and an investigator at the Center of Excellence for Vaccine Research (CEVR) at UConn. He received a BS in Biology from the Federal University of Rio Grande do Sul in Brazil, and earned a PhD in Comparative Pathology at the University of California, Davis. He joined UConn as an Assistant Professor in 2008. He is a member of the American Society for Virology (ASV), the American Society for Microbiology (ASM), the American Association of Immunologists (AAI), and the American Society of Gene & Cell Therapy (ASGCT). In 2013 he received the ASM Outstanding Service Award to the Committee on Global Engagement. He serves as a grant reviewer for the National Institutes of Health (NIH) since 2005.